These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 6702130

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP.
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Significance of lymph nodes dissection of lung cancer treatment].
    Konaka C, Kato H, Sato M, Hiyoshi T, Saito H.
    Kyobu Geka; 1994 Jan; 47(1):45-8. PubMed ID: 8277633
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
    Riquet M, Manac'h D, Le Pimpec-Barthes F, Dujon A, Chehab A.
    Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
    [Abstract] [Full Text] [Related]

  • 11. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, Hölscher AH.
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic models for Hodgkin's disease].
    Panyshin GA, Datsenko PV, Sotnikov VM, Mel'nik IuD.
    Vopr Onkol; 2006 Apr; 52(5):538-43. PubMed ID: 17168362
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S, Bertoni F, Zanella L, Setola E, Bacchini P, Alberghini M, Versari M, Bacci G.
    Cancer; 2004 May 01; 100(9):1936-42. PubMed ID: 15112275
    [Abstract] [Full Text] [Related]

  • 17. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P, Bastion Y, Divine M, Nedellec G, Ferrant A, Gabarre J, Reman O, Lepage E, Fermé C.
    Cancer; 1996 Sep 15; 78(6):1293-9. PubMed ID: 8826953
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A, Turna A, Kocaturk C, Gunluoglu MZ, Aydogmus U, Urer N, Bedirhan MA, Gurses A, Dincer SI.
    Ann Thorac Surg; 2009 Apr 15; 87(4):1014-22. PubMed ID: 19324121
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.